Cargando…
Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS
Serum prostate-specific antigen (PSA) is currently the most used biomarker in clinical practice for prostate cancer (PCa) detection. However, this biomarker has several drawbacks. In this work, an untargeted gas chromatography-mass spectrometry (GC-MS)-based metabolomic profiling of PCa cells was pe...
Autores principales: | Lima, Ana Rita, Araújo, Ana Margarida, Pinto, Joana, Jerónimo, Carmen, Henrique, Rui, Bastos, Maria de Lourdes, Carvalho, Márcia, Guedes de Pinho, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882858/ https://www.ncbi.nlm.nih.gov/pubmed/29615722 http://dx.doi.org/10.1038/s41598-018-23847-9 |
Ejemplares similares
-
GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells
por: Lima, Ana Rita, et al.
Publicado: (2018) -
GC-MS Metabolomics Reveals Distinct Profiles of Low- and High-Grade Bladder Cancer Cultured Cells
por: Rodrigues, Daniela, et al.
Publicado: (2019) -
GC‐MS metabolomics‐based approach for the identification of a potential VOC‐biomarker panel in the urine of renal cell carcinoma patients
por: Monteiro, Márcia, et al.
Publicado: (2017) -
A Panel of Urinary Volatile Biomarkers for Differential Diagnosis of Prostate Cancer from Other Urological Cancers
por: Lima, Ana Rita, et al.
Publicado: (2020) -
Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine
por: Lima, Ana Rita, et al.
Publicado: (2019)